Home › Trial NCT01966133
TACE as an Adjuvant Therapy After Hepatectomy for HCC
- Trial IDNCT01966133
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorJia Fan
- Enrollment280
- Start date2011-08
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.